Safety, Immunogenicity, and Efficacy of Cytomegalovirus Vaccines: A Systematic Review of Randomized Controlled Trials
<b>Background/Objectives:</b> Cytomegalovirus (CMV) is widespread and mostly causes asymptomatic infections in immunocompetent hosts, but it may lead to severe and life-threatening diseases in immunocompromised individuals, such as transplant patients and congenitally infected children,...
Saved in:
Main Authors: | Manuela Chiavarini, Anita Genga, Giorgia Maria Ricciotti, Marcello Mario D’Errico, Pamela Barbadoro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/13/1/85 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)
by: Adewunmi Akingbola, et al.
Published: (2025-12-01) -
Incidence of ophthalmic manifestations in congenital cytomegalovirus (CMV)
by: Jennifer L. Rossen, et al.
Published: (2025-01-01) -
Congenital cytomegalovirus - current state of knowledge on the treatment and prevention of fetuses and newborns
by: Katarzyna Miedzińska, et al.
Published: (2025-01-01) -
Timing of congenital cytomegalovirus diagnosis and missed opportunities
by: Mallory R. Baker, et al.
Published: (2025-02-01) -
Exploitation of Unconventional CD8 T-Cell Responses Induced by Engineered Cytomegaloviruses for the Development of an HIV-1 Vaccine
by: Joseph Bruton, et al.
Published: (2025-01-01)